We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Raman Imaging Probes for Detecting Enzyme Activities Could Aid Disease Diagnosis

By LabMedica International staff writers
Posted on 02 Jun 2023

Enzymes play a crucial role in various biological processes, which makes them suitable biomarkers for disease detection. More...

For instance, cancer diagnosis often uses fluorescence imaging to identify cancer-related enzymes that have multiplied in cells affected by the disease. Given the heterogeneous nature of tumor tissues, being able to detect multiple enzyme activities at once could enhance the precision of cancer visualization and diagnosis. However, detecting multiple enzyme activities using fluorescence imaging can be challenging in heterogeneous tumor tissues and other complex biological phenomena. Raman spectral imaging, with its narrower spectral width, provides a promising alternative for multiplex biological imaging with molecular probes. Over time, a number of functional and activatable Raman probes (dyes) have been developed for bioanalyte detection, but their use for enzyme activity detection has been limited. In addition, prior design strategies have been unsuccessful in controlling the diffusion of enzyme-generated hydrolysis product of these probes, making it difficult to identify areas with targeted enzyme activity in tissues.

Now, a team of researchers led by Tokyo Institute of Technology (Tokyo Tech, Tokyo, Japan) has come up with a novel molecular design approach, taking cues from aggregation-based fluorescent probes. The team has developed activatable Raman probes based on 9CN-rhodol using a novel mechanism for Raman signal activation. The researchers have shown that Raman imaging has more potential for detecting multiple enzyme activities compared to fluorescence imaging. This innovative strategy allows the creation of highly activatable Raman probes that possess strong aggregation and multiplexing ability, providing a promising tool for expanding the range of Raman probes that can detect multiple enzyme activities in heterogeneous biological tissues.

The researchers first synthesized 9CN-rhodol derivatives and chose two, 9CN-JR and 9CN-JCR, to design the activatable Raman probes. They tested the enzyme detection capabilities of both probes in live cells, using a dual-color stimulated Raman scattering (SRS) imaging technique. Among the two, 9CN-JCR outperformed and proved to be the more effective probe for multiplexing. The team then isotope-labeled the nitril group of 9CN-JCR scaffold with Carbon-13 (13C) and Nitrogen-15 (15N), and developed two new isotope edited 9CN-JCR probes for γ-glutamyl transpeptidase and dipeptidyl peptidase-4 enzymes. These 9CN-JCR-based probes successfully detected all enzyme activities simultaneously in the live cell culture.

Additionally, the probes enabled ex vivo imaging of specific cell areas showing targeted enzyme activity in Drosophila wing disk and fat body. The high spatial selectivity and sensitivity exhibited by the 9CN-JCR probes were attributed to the electronic pre-resonance effect of the scaffold dye and aggregate formation of the hydrolysis products formed by probe-cell interaction. These rhodol-based probes could aggregate when reacting with enzymes, which enhanced their intracellular retention and boosted the SRS signal intensity during enzyme detection. Overall, the approach presented in this study could support the development of highly specific activatable Raman probes for simultaneous detection of multiple enzyme activities.

"Our aggregation-based molecular design strategy for Raman probes will offer substantial advantages for applications involving the investigation of enzyme activity associated with diseases and essential biological activities," said Professor Mako Kamiya of Tokyo Tech who led the research.

Related Links:
Tokyo Tech 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Gold Member
Platelet Function Analyzer
PL-12
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.